Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 120   

Articles published

GSK 1,648.13 -4.87 (-0.29%)
price chart
How safe is GlaxoSmithKline plc's dividend?
GlaxoSmithKline (LSE: GSK) is one of the largest firms listed in the FTSE 100 by market capitalisation and as such, is bound to attract the attention of dividend-seeking investors.
Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?
AstraZeneca(LSE: AZN) and GlaxoSmithKline(LSE: GSK) are two companies that have benefitted from this trend. Indeed, since Brexit shares in Astra have gained a staggering 32% and Glaxo's shares have gained 19.4%, both outperforming the wider FTSE ...
GlaxoSmithKline Plc (NYSE:GSK) Unveils Take 5 for Meningitis
GlaxoSmithKline Plc (NYSE:GSK) (GSK) has introduced Take 5 for Meningitis, an educational campaign that seeks to promote meningitis awareness.
GlaxoSmithKline plc (ADR)(GSK) and Alphabet Inc (GOOGL) Team Up for Joint Venture
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Alphabet Inc's (NASDAQ:GOOGL) Verily Life Sciences, formerly known as Google Life Sciences, come together to form a new joint venture.
GlaxosmithKline teams up with Google sister firm in bioelectronics venture  Proactive Investors UK
Glaxo, Alphabet Form Venture to Make Bioelectronic Medicines  Bloomberg
Shire PLC Lags GlaxoSmithKline plc, AstraZeneca plc, Pfizer Inc. And Johnson ...
This is less than the gains made by global sector peers such as GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN), Pfizer Inc. (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ).
GlaxoSmithKline plc 1.5% Potential Upside Indicated by Cantor Fitzgerald
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'HOLD' today by analysts at Cantor Fitzgerald.
A report released earlier today by Cantor Fitzgerald about (LON:GSK ...  Breaking Finance News
Is it too late to buy GlaxoSmithKline plc, Glencore plc and Royal Bank of ...
Medical ace GlaxoSmithKline (LSE: GSK) has taken off in the weeks following the EU referendum, the universal and evergreen nature of drugs demand making the firm a brilliant safe haven.
Are GlaxoSmithKline plc and GW Pharmaceuticals plc simply too expensive?
However much we may like a business, paying too much for the shares will lower our profits at best and lose us money at worst. Today, I'm looking at whether FTSE 100 pharma giant GlaxoSmithKline(LSE: GSK) and AIM-listed cannabis products specialist ...
GlaxoSmithKline plc 11.3% Potential Upside Indicated by JP Morgan Cazenove
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Retains' with the recommendation being set at 'NEUTRAL' today by analysts at JP Morgan Cazenove.
JP Morgan Indicates Potential 10.98% Increase In Shares Of GlaxoSmithKline PLC  Fiscal Standard
GlaxoSmithKline PLC (NYSE:GSK) Updated Price Targets
08/17/2016 - GlaxoSmithKline PLC had its “hold” rating reiterated by analysts at Shore Capital Stockbrokers. 08/08/2016 - GlaxoSmithKline PLC had its “buy” rating reiterated by analysts at Citigroup. 08/02/2016 - GlaxoSmithKline PLC had its “buy ...
Royal Bank Of Canada Decreased Stake in Glaxosmithkline Plc (NYSE:GSK) by ...  Press Telegraph